Peter Meldrum, Who Lost a Fight to Patent Genes, Dies at 71 The New York Times
He led Myriad Genetics, whose patents on the BRCA1 and BRCA2 genes, associated with breast cancer, were invalidated by the Supreme Court.
Peter Meldrum, Who Lost a Fight to Patent Genes, Dies at 71 The New York Times
He led Myriad Genetics, whose patents on the BRCA1 and BRCA2 genes, associated with breast cancer, were invalidated by the Supreme Court.